Edwards Lifesciences (EW) Short term Debt (2009 - 2018)
Edwards Lifesciences (EW) posted quarterly Short term Debt of $598.6 million for Q1 2018, up 1057.83% quarter-over-quarter from $51.7 million in Q4 2017.
Edwards Lifesciences (EW) Short term Debt (2009 - 2018) Analysis & Trends
Edwards Lifesciences' Short term Debt history runs 6 years deep, the most recent figure standing at $598.6 million for Q1 2018.
- In Q1 2018, Short term Debt changed N/A year-over-year to $598.6 million; the TTM figure through Mar 2018 stood at $598.6 million (changed N/A YoY), while the FY2017 annual figure was $51.7 million, changed N/A from the prior year.
- Short term Debt for Q1 2018 stood at $598.6 million, up from $51.7 million in the prior quarter.
- The five-year high for Short term Debt was $598.6 million in Q1 2018, with the low at $41.5 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 599.90 Mn |
| Jun 30, 2018 | 599.20 Mn |
| Mar 31, 2018 | 598.60 Mn |
| Dec 31, 2017 | 51.70 Mn |
| Sep 30, 2017 | 41.50 Mn |
| Dec 31, 2012 | 189.30 Mn |
| Dec 31, 2011 | 150.40 Mn |
| Mar 31, 2011 | 149.50 Mn |
| Dec 31, 2010 | 41.80 Mn |
| Sep 30, 2010 | 100.60 Mn |
| Dec 31, 2009 | 11.40 Mn |